The Searle Company Limited (PSX:SEARL)
86.99
+0.10 (0.12%)
At close: Jun 27, 2025
The Searle Company Revenue
The Searle Company had revenue of 7.00B PKR in the quarter ending March 31, 2025, with 4.66% growth. This brings the company's revenue in the last twelve months to 29.12B, up 34.47% year-over-year. In the fiscal year ending June 30, 2024, The Searle Company had annual revenue of 29.40B with 13.97% growth.
Revenue (ttm)
29.12B
Revenue Growth
+34.47%
P/S Ratio
1.52
Revenue / Employee
7.23M
Employees
4,026
Market Cap
44.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 29.40B | 3.60B | 13.97% |
Jun 30, 2023 | 25.80B | -4.11B | -13.75% |
Jun 30, 2022 | 29.91B | 3.69B | 14.07% |
Jun 30, 2021 | 26.22B | 5.74B | 28.06% |
Jun 30, 2020 | 20.47B | 2.41B | 13.36% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.15B |
Abbott Laboratories (Pakistan) | 69.49B |
Highnoon Laboratories | 25.51B |
AGP Limited | 26.27B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 12.97B |
Ferozsons Laboratories | 18.16B |
Otsuka Pakistan | 3.69B |